Alzheimer. Dementia in Alzheimer disease
Conditions
Interventions
Intervention group: Patients with moderate form of Alzheimer's, who, according to the neurologist responsible for the treatment, have a low probability of responding to the treatment, are selected to
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 60 years MMSE less than 18 The possibility of performing neurocognitive evaluations Expected survival greater than 12 months
Exclusion criteria
Exclusion criteria: History of brain radiotherapy History of seizure Active skin disease in the scalp History of malignancy except skin cancer History of stroke in the last 3 months Non-compliance with brain radiotherapy Impossibility of obtaining informed consent from the patient or substitute decision maker
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neurocognitive performance after treatment. Timepoint: before treatment, 3 months and 6 months after treatment. Method of measurement: CDR.;Complications. Timepoint: 3 months and 6 months after treatment. Method of measurement: Based on Common Terminology Toxicity Criteria (Version 5.0). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactnima mousavi darzikalaei
Tehran University of Medical Sciences
Outcome results
None listed